ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS
This study aims to understand the role of blood platelets in several autoimmune diseases, including lupus, scleroderma, ANCA vasculitis, inflammatory myositis, Sjögren's syndrome, and rheumatoid arthritis. Platelets, known for blood clotting, appear to behave differently in people with these conditions, especially when their disease is active. They might be interacting with immune cells and making the immune system overactive. By studying these interactions, researchers hope to discover new ways to diagnose active disease and develop new treatments that target platelets. This could lead to a better understanding of these conditions and provide new options for patients.
At a glance
What is this study about?
You might know platelets as the tiny cells in your blood that help stop bleeding by forming clots. However, in people with certain long-term conditions where the immune system mistakenly attacks the body, like lupus or rheumatoid arthritis, platelets seem to act differently. They can become "activated," which means they start to behave in a way that might make the disease worse.
Researchers have found that these activated platelets can interact with other important immune cells, potentially boosting the body's overactive immune response. For example, in lupus, activated platelets seem to stop certain immune cells from doing their job of keeping the immune system in check. If we can understand exactly how these platelets are involved and why they become activated, we might find new ways to help manage these conditions.
This study will investigate these platelet-immune cell interactions further, comparing what happens in lupus with other similar conditions. The goal is to get a clearer picture of platelets' role in these diseases. This understanding could be very important, as it might lead to new ways to spot when a disease is active, and even open the door to completely new treatments that focus on controlling how platelets behave, offering fresh hope for patients.
Key takeaways
- Studies how blood platelets act differently in autoimmune diseases.
- Aims to understand if platelets contribute to making conditions worse.
- Could lead to new ways to diagnose disease activity.
- Might help identify targets for future treatments.
- Focuses on lupus (SLE), scleroderma, vasculitis, myositis, Sjögren's, and rheumatoid arthritis.
- Participation involves providing blood samples, exact details to be confirmed.
Who may be eligible?
To join this study, you need to be between 18 and 70 years old. You also need to be covered by a health insurance scheme, like the NHS, and be able to understand what the study is about and agree to take part by signing a consent form.
Crucially, you must have a confirmed diagnosis of one of the following conditions: Systemic Lupus Erythematosus (Lupus), Systemic Scleroderma, ANCA Vasculitis, Inflammatory Myositis, Gougerot-Sjögren Syndrome (Sjögren's syndrome), or Rheumatoid Arthritis. Your doctor will use specific ways to check you meet the criteria for your condition.
You cannot join if you are already in another study that prevents you from participating in this one, or if you're unable to give informed consent, for example, due to an emergency or if you're under legal protection that prevents you from making such decisions.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you between 18 and 70 years old?
- Do you have health insurance coverage (like NHS)?
- Have you been diagnosed with Lupus, Scleroderma, Vasculitis, Myositis, Sjögren's, or Rheumatoid Arthritis?
- Are you able to understand the study and willing to give your consent?
- Are you not currently part of another study that would prevent you from joining this one?
What does participation involve?
The information provided does not detail what taking part in this specific study involves in terms of visits, assessments, medication, or duration. Generally, studies looking at blood samples, like this one, might involve:
* **Initial Visit:** You would likely have an appointment where a doctor or nurse explains the study in detail, answers your questions, and helps you with the consent form. They would confirm your diagnosis and check if you meet all the criteria. * **Blood Samples:** The main part of your involvement would likely be giving one or more blood samples. These samples would be taken by a trained professional and used to study your platelets and how they interact with other cells. * **Follow-up:** Depending on the study design, there might be repeat blood samples taken over a period of time, or it might be a single set of samples. The study description doesn't mention any new medications being given, so it's likely observational.
It's important to discuss the exact details of what's involved with the study team if you're interested.
Potential risks and benefits
Locations (1)
- Hopitaux Universitaires de Strasbourg - Hopital de Hautepierre - Service de rhumatologieVerified postcodeStrasbourg, France· Recruiting
Common questions
What are platelets?
Platelets are tiny cells in your blood, mostly known for helping your blood clot and stop bleeding if you get a cut.
What does 'autoimmune disease' mean?
It means your body's immune system, which normally fights off infections, mistakenly attacks your own healthy tissues and organs.
Will I get a new treatment in this study?
No, this study is about understanding how diseases work; it's not testing new treatments on participants. It's more about laboratory research.
How long will I be involved if I join?
The information given doesn't specify the duration. It's important to ask the study team how many visits and how much time it would take.
Will my regular medical care change if I take part?
No, this study should not change your usual medical care or treatments for your condition.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.